Supplemental Digital Content

Similar documents
National Surveillance of Nosocomial Septicemia (Hospital-wide)

SUPPLEMENTARY MATERIAL

Brief Communication Clinical Microbiology

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology

General Bacteriology 1 (5080) and 2 (5081). List of microbes included in the specimens linked to the corresponding photo replies since

Received 1 March 2011/Returned for modification 19 April 2011/Accepted 20 May 2011

General Bacteriology 1 and 2. List of samples and the microbes linked to the corresponding photo replies since

M O L E C U L A R G E N E T I C S

Microsan rx Anti-Microbial Healthcare Professional Soap. Organism Positives ATCC #

Consultation on the Revision of Carbapenem Breakpoints

INFECTIOUS DISEASE. Page 2

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

This material is supported in part by unrestricted educational grants from: Abbott, Bayer HealthCare, Merck Frosst, Roche Diagnostics, and Wyeth Inc.

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Sep Oct Nov Dec Total

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Optimizing MALDI-TOF Use. Clinical Impact Laboratory Impact

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection)

Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05

MALDI-TOF mass spectrometry for direct bacterial identification

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units

VITEK MS Implementation of Mass Spectrometry

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

MERREM IV. meropenem PRODUCT INFORMATION COOH CH 3

Patient: Ima Sample. Accession: Shiloh Rd, Ste 101. Collected: 2/10/2018. Received: 2/12/2018 Alpharetta GA

INTRA-ABDOMINAL INFECTIONS - II

Efficacy Data. Disinfectant Cleaner & Odor Counteractant EPA REG. #

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine

Scheme Description. Clinical Microbiology Laboratory Scheme

Physical Properties Appearance: Clear Liquid Fragrance: Fragrance Free Form: Gel ph: INCI Name*

MICROBIOLOGY CONTROL PRODUCTS

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010

MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS. Patient Information Leaflet

Original Article Clinical Microbiology INTRODUCTION

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory AUGMENTIN 625 / 1000 DUO

Patient: Ima Sample. Accession: Shiloh Rd, Ste 101. Collected: 9/4/2018. Received: 9/6/2018 Alpharetta GA

MAGNEX Injection (Sulbactam Sodium/Cefoperazone Sodium 1:1)

Abstract. Introduction. Editor: F. Allerberger

M E D I C A L L A B O R A T O R Y

Cefuroxime (as sodium)

Summary of Product Characteristics

SURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data

Shift from culture screening to molecular testing

ZOSUL Injection (Cefoperazone Sodium + Sulbactam Sodium) Cefoperazone Sodium Plus Sulbactam Sodium Injection Zosul

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE

M E D I C A L L A B O R A T O R Y

PATHOGEN DETECTION WITH THE FILMARRAY

Syndromic Testing: The right test, the first time.

For use with Sofia only

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis

Objective: To assess the incidence of healthcare-associated infections (HAI) and the prevalence

Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct

Torres, Brian Carlmichael L., Ma. Luisa G. Daroy, Juan s. Lopez, Vanessa Oh, Marie Joan Loy, Prospero ma. Tuaño, and Ronald R. Matias Research and

New Zealand Data Sheet

IMIPENEM CILASTATIN SODIUM

Yes No Unknown. In hospital Out of hospital Unknown. Blood Pump Drive Unit Failure External Control System Failure. Yes No Unknown

Summary of Product Characteristics

PREVENTIVE MEDICINE - LABORATORY

PRODUCT INFORMATION. Meropenem Kabi powder for intravenous injection or infusion 500 mg 1 g

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

Infection Data: Form Updates

NEW ZEALAND DATA SHEET. Each vial contains 263 mg, 789 mg or g of cefuroxime sodium, equivalent to 250 mg, 750 mg or 1.5 g of cefuroxime.

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory AUGMENTIN DDS

Client Services Manual

IMMUVIEW S. PNEUMONIAE ANTIGEN TEST. Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid.

S. Q. van Veen,* E. C. J. Claas, and Ed J. Kuijper. Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands

Supplementary Figure 1

ESCMID Online Lecture Library. by author

On-demand diagnosis of TB and rifampinresistance using the Xpert MTB/RIF assay: the present and the future.

Next Generation in Acne treatment. A new approach in Acne Treatment. GramaDerm. Advanced Acne Vulgaris Management with Microcyn Technology

Molecular Testing in Infectious Diseases. Objectives 5/9/2014. Implementing Molecular Testing for Infectious Diseases Diagnosis

M E D I C A L L A B O R A T O R Y

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014

IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST. SSI Diagnostica

ALCOHOL INSTANT HAND SANITIZER

Cefuroxime (as sodium)

Molecular approaches in the diagnosis of sepsis in neutropenic patients with haematological malignances

2.5 L / 2.64 U.S. Qt. DANGER. Disinfectant Cleaner Bactericidal Fungicidal Mildewstatic Deodorizing *Virucidal KEEP OUT OF REACH OF CHILDREN FIRST AID

Pathogen Matrix PATHOGEN CLAIM PPM (MG/L) / ORP TIME (MIN) DETAILS SOURCE

KOMAR UNIVERSITY OF SCIENCE AND TECHNOLOGY (KUST) Medical Bacteriology Syllabus (Theory) Spring 2016

Client Services M anual

DISEASE OUTBREAKS SUMMARY

Microbial DNA qpcr Array Oral Disease

Superbugs in Dental Practice: A Narrative Review

Potential Reimbursement CPT Codes

Expert rules in antimicrobial susceptibility testing: State of the art

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

PHYSICIANS CIRCULAR. Tablets NOROXIN (norfloxacin, USP)

Utility of Gram stain in the clinical management of suspected ventilator-associated pneumonia Secondary analysis of a multicenter randomized trial

DIRECTIONS FOR USE USE

1430 West McCoy Lane Santa Maria, CA p:

Blue coloring. Enrichment medium for the simultaneous detection of total coliforms and Escherichia coli in water, foods and dairy products.

Primaxin IV Injection

Transcription:

Rapid Diagnosis of Infection in the Critically Ill (RADICAL), a multicenter study of molecular detection in bloodstream infections, pneumonia and sterile site infections Jean-Louis Vincent, David Brealey, Nicolas Libert, Nour Elhouda Abidi, Michael O Dwyer, Kai Zacharowski, Malgosia Mikaszewska-Sokolewicz, Jacques Schrenzel, Francois Simon, Mark Wilks, Marcus Picard Maureau, Donald B. Chalfin, David J. Ecker, Rangarajan Sampath, Mervyn Singer and the RADICAL Team Supplemental Digital Content

Subject Identifier Table S1: Blood-stream infection organisms reported using microbiology and the PCR/ESI-MS result in the same patient Microbiology PCR/ESI-MS Q Score Level (GE/ ml) Matched results 1001 Klebsiella pneumoniae Klebsiella pneumoniae 0.99 173 Yes 1016 Candida albicans 0.85 4 No 1028 Klebsiella pneumoniae Klebsiella pneumoniae 0.99 222 Yes 1032 Staphylococcus aureus Staphylococcus aureus 0.99 12 Yes 1033 0.97 16 Yes 2005 Enterobacter cloacae Enterobacter cloacae complex 0.97 15 Yes 2006 Pseudomonas Pseudomonas 0.99 215 Yes 2028 Staphylococcus aureus Staphylococcus aureus 0.99 74 Yes 2032 Enterococcus faecium Enterococcus faecium 0.99 337 Yes 2034 Citrobacter freundii Citrobacter freundii 0.99 142 Yes 2037 Staphylococcus aureus Negative.. Negative by PCR 2043 Candida albicans Candida albicans 0.94 6 Yes 2045 0.99 176 Yes 2049 Staphylococcus aureus 0.99 173 No 2052 oralis Finegoldia magna 0.96 52 No 2055 Hafnia alvei Hafnia alvei 0.97 68 Yes 2057 0.99 142 Yes 2067 0.96 2 Yes 3011 Acinetobacter 0.89 3 No baumannii 3047 Gram- cocci Klebsiella pneumoniae 0.99 82 Yes 4001 Candida parapsilosis Candida parapsilosis 0.99 178 Yes 4011 0.99 85 Yes 4012 Staphylococcus aureus Staphylococcus aureus 0.99 191 Yes 4012 Staphylococcus aureus Staphylococcus aureus 0.99 206 Yes 4016 Bacteroides fragilis Bacteroides 0.96 55 Yes fragilis/thetaiotaomicron 4018 0.99 48 Yes 4026 Enterobacter cloacae Klebsiella pneumoniae 0.99 171 No 4029 Enterobacter cloacae Enterobacter cloacae complex 0.99 158 Yes 4029 Enterobacter cloacae Enterobacter cloacae complex 0.99 156 Yes 4033 Staphylococcus aureus Staphylococcus aureus 0.99 210 Yes 4037 0.97 151 Yes 4037 0.98 247 Yes 4061 pneumoniae mitis/pneumoniae; pneumoniae 0.98 54 Yes 5009 0.98 13 Yes 5009 0.98 8 Yes 5040 Negative.. Negative by PCR 5047 0.99 197 Yes 5048 Staphylococcus aureus Staphylococcus aureus 0.99 258 Yes

5048 Staphylococcus aureus Staphylococcus aureus 0.99 169 Yes 5050 Enterococcus faecalis Negative.. Negative by PCR 5057 0.99 140 Yes 5063 Clostridium Negative.. Negative by PCR paraputrificium 6006 Pseudomonas sp. Pseudomonas 0.98 301 Yes 6006 Pseudomonas Pseudomonas 0.98 200 Yes 6010 0.99 244 Yes 6010 0.99 264 Yes 6014 Stenotrophomonas Stenotrophomonas maltophilia 0.98 221 Yes maltophilia 6046 0.99 112 Yes 6051 0.99 242 Yes 6051 0.99 246 Yes 6054 Staphylococcus aureus Staphylococcus aureus 0.99 187 Yes 6054 Staphylococcus aureus Staphylococcus aureus 0.99 165 Yes 6068 Pseudomonas Pseudomonas 0.99 646 Yes 6068 Pseudomonas Pseudomonas 0.99 446 Yes 6070 Enterococcus faecium Negative.. Negative by PCR 7002 Staphylococcus aureus Staphylococcus aureus 0.98 145 Yes 7010 pyogenes Negative.. Negative by PCR 8001 Listeria monocytogenes Negative.. Negative by PCR 8002 Morganella morganii Morganella morganii 0.96 9 Yes 8008 Klebsiella pneumoniae Klebsiella pneumoniae 0.97 4 Yes 8038 Pseudomonas Candida albicans 0.99 103 No 9005 0.99 214 Yes 9005 0.99 159 Yes 9010 0.98 83 Yes 9030 Staphylococcus aureus Staphylococcus aureus 0.99 175 Yes 9030 Staphylococcus aureus Staphylococcus aureus 0.99 192 Yes 9033 Pseudomonas Pseudomonas 0.98 45 Yes

Table S2: Summary of organisms reported by PCR/ESI-MS that were negative by culture in blood-stream infection samples PCR/ESI-MS reported microbes negative by culture Total Acinetobacter baumannii 1 Bacteroides fragilis/thetaiotaomicron 2 Candida albicans 11 Candida glabrata 2 Candida tropicalis 2 Citrobacter koseri 5 Enterobacter cloacae complex 3 Enterococcus faecalis 7 Enterococcus faecium 23 64 vulneris 1 Finegoldia magna 1 Fusobacterium nucleatum 3 Granulicatella adiacens 1 Haemophilus influenzae 5 Hafnia alvei 1 Helicobacter cetorum;helicobacter pylori 1 Klebsiella oxytoca 5 Klebsiella pneumoniae 8 Klebsiella variicola 1 Lactobacillus acidophilus/amylovorus/crispatus 1 Lactobacillus fermentum 1 Lactobacillus gasseri 1 Lactococcus lactis 1 Micrococcus luteus 1 Morganella morganii 2 Mycobacterium africanum/bovis/canettii/tuberculosis 2 Neisseria meningitidis 2 Prevotella denticola 1 Pseudomonas 2 Raoultella ornithinolytica/planticola 2 Roseomonas gilardii 1 Rothia mucilaginosa 2 Shigella boydii 1 Staphylococcus aureus 17 Staphylococcus lugdunensis 1 Stenotrophomonas maltophilia 1 agalactiae 1 mitis/pneumoniae; pneumoniae 4 oralis/pneumoniae 1 pneumoniae 2

pseudopneumoniae 1 pyogenes 6

Table S3: Summary of replicate testing results 168 samples for which there were two replicates of PCR/ESI-MS results Replicate 2 Replicate 1 Positive Negative Positive 52 12 Negative 13 91 158 samples for which there were two replicates of culture results Replicate 2 Positive Negative Replicate 1 Positive 12 6 Negative 3 137

Table S4: Replicate sample test results from the 80 cases where either method was positive in one or both BSI replicates. In 77 instances, PCR/ESI-MS was positive in one or both replicates while in 3 only culture was positive. Levels of detection (GE/mL) for matched replicate PCR/ESI-MS results were comparable Standard of care organism detection PCR/ESI-MS organism identification PCR/ESI-MS level (GE/mL) Subje ct Identi fier Primary result Replicate result Primary result Replicate result Primary result Replic ate result 2039 Negative Negative Mycobacterium africanum/bovis/canettii/ tuberculosis Mycobacterium africanum/bovis/canettii/ tuberculosis 752 667 2043 Candida albicans Negative Candida albicans Candida albicans 6 190 2047 Negative Negative Enterococcus faecium Enterococcus faecium 11 67 2049 Negative Staphylococ cus aureus Negative.. 2053 Negative Negative Negative 74. 2055 Hafnia alvei Negative Hafnia alvei Hafnia alvei 68 4 2067 Negative Negative. 2 2103 Negative Negative Negative Enterococcus faecium. 13 2104 Negative Negative Candida tropicalis Candida tropicalis 7 10 2106 Negative Negative Negative 17. Staphylococ Staphylococ 4012 Staphylococcus aureus Staphylococcus aureus 191 206 cus aureus cus aureus Enterobacte Enterobacte Enterobacter cloacae Enterobacter cloacae 4029 158 156 r cloacae r cloacae complex complex 4037 151 247 4040 Negative Negative Negative Klebsiella pneumoniae. 138 4081 Negative Negative 322 280 5009 13 8 5013 Negative Not Tested Haemophilus influenzae Negative 382. 5014 Negative Negative 7 17 5018 Negative Not Tested Negative Finegoldia magna. 15 5019 Negative Negative 13 59 5023 Not Tested Negative oralis/pneumoniae oralis/pneumoniae 181 164 5026 Negative Negative Negative 5. 5027 Negative Negative 234 171 5028 Negative Negative 181 92 5030 Negative Not Tested Negative Citrobacter koseri. 142 5031 Negative Negative Enterococcus faecium Enterococcus faecium 57 116 5032 Negative Negative Citrobacter koseri Citrobacter koseri 146 134 5038 Negative Not tested 5 15 5039 Negative Negative Negative Candida albicans. 5

5040 5041 Negative Not tested Not tested Negative. 7 Lactobacillus acidophilus/amylovorus/ crispatus Negative 153. 5045 Negative Negative 532 200 5048 Staphylococ cus aureus Staphylococ cus aureus Staphylococcus aureus Staphylococcus aureus 258 169 5049 Negative Not Tested Negative Staphylococcus aureus. 3 5053 Negative Not Tested Staphylococcus aureus Negative 248. 5054 Negative Negative 25 57 5058 Negative Negative Staphylococcus aureus Staphylococcus aureus 348 6 5062 Negative Negative 14 24 5063 Clostridium paraputrifici um Negative Negative Negative.. 5071 Negative Negative Neisseria meningitidis Neisseria meningitidis 199 210 6001 Negative Negative Klebsiella oxytoca Klebsiella oxytoca 39 49 6004 Negative Negative 35 41 6005 Negative Negative Enterococcus faecium Enterococcus faecium 22 23 6006 6010 Pseudomon as sp. Pseudomon as Pseudomonas Pseudomonas 301 200 244 264 6012 Negative Negative Enterococcus faecium Enterococcus faecium 61 39 6014 Stenotropho monas maltophilia Negative Stenotrophomonas maltophilia Stenotrophomonas maltophilia 221 5 6016 Negative Negative Citrobacter koseri Citrobacter koseri 142 100 6018 Negative Negative Enterococcus faecium Enterococcus faecium 27 37 6022 Negative Negative Negative. 4 6030 Negative Negative Negative Bacteroides fragilis/thetaiotaomicron. 19 6031 Negative Negative Enterococcus faecalis Enterococcus faecalis 6 15 6032 Negative Negative 6 4 6039 Negative Negative Candida albicans Negative 5. 6044 Negative Negative Klebsiella pneumoniae Klebsiella pneumoniae 214 191 6046 Negative 181 112 6050 Negative Negative 23 26 6051 242 246 6054 Staphylococ Staphylococ cus aureus cus aureus Staphylococcus aureus Staphylococcus aureus 187 165 6055 Negative Negative Enterococcus faecalis Negative 9. 6061 Negative Negative Klebsiella oxytoca Klebsiella oxytoca 90 114 6067 Negative Negative 6068 6070 Pseudomon as Enterococcu s faecium Pseudomon as pyogenes Pseudomonas pyogenes Pseudomonas 17 4 646 446 Negative Negative Negative.. 6072 Negative Negative 207 202

6082 Negative Negative Negative Morganella morganii. 3 6083 Negative Negative Morganella morganii Negative 3. 6088 Negative Negative 71 171 6091 Negative Negative 3 7 6092 Negative Negative 6094 Negative Negative pyogenes mitis/pneumoniae; pneumoniae pyogenes mitis/pneumoniae; pneumoniae 130 106 20 17 7008 Negative Negative Shigella boydii Negative 136. 7010 Streptococc us pyogenes Negative Negative Negative.. 8026 Not Tested Negative Negative pseudopneumoniae. 115 9002 Negative Negative Enterococcus faecium Negative 3. 9005 214 159 9021 Negative Negative 234 495 9030 Staphylococ cus aureus Staphylococ cus aureus Staphylococcus aureus Staphylococcus aureus 175 192 9031 Negative Negative Staphylococcus aureus Staphylococcus aureus 48 44 9034 Negative Negative Negative 3.